Benfotiamine is a fat-soluble form of vitamin B1 that supports nerve health and glycation defense.

Benfotiamine is a fat-soluble derivative of thiamine (B1) that achieves much higher tissue concentrations than water-soluble thiamine. It's the form most studied for diabetic complications and nerve health because it crosses cell membranes more efficiently.
Most commonly for diabetic neuropathy, nerve pain, and supporting glycation defense in people with elevated blood sugar. It activates transketolase, an enzyme that diverts glucose away from pathways that produce advanced glycation end products.
Clinical trials use 150–600 mg per day, typically split across two doses with meals. Most people start at 150–300 mg per day and titrate up.
In randomized trials, symptom improvement (pain, paresthesia, vibration sense) appears within 3–6 weeks at 300–600 mg per day, with continued improvement through 12 weeks. Full benefit may take 3–6 months. Don't expect immediate effects.
Both work through different mechanisms and stack well. ALA is a broader antioxidant; benfotiamine specifically blocks glycation pathways and supports thiamine-dependent nerve metabolism. Many neuropathy protocols combine 600 mg ALA + 300 mg benfotiamine daily.
Yes. Benfotiamine is also used for cardiovascular health (especially in people with elevated A1C), Alzheimer's prevention research, and nerve support after alcohol use. Anyone with elevated blood glucose, A1C, or AGE-related concerns can benefit.
Benfotiamine is well-tolerated even at high doses. Rare side effects include mild stomach upset, skin rash, and a sulfur-like body odor at very high doses. It does not cause the flushing or B-vitamin nausea sometimes seen with high-dose B-complex.
Yes, and they're often paired. Metformin can lower B12 and B1 status over time. Benfotiamine pairs well with metformin to address the thiamine depletion and to add a layer of glycation defense to glucose lowering.
Yes. Studies have followed people on 300–600 mg per day for 12+ months without safety concerns. Excess thiamine is excreted in urine. No known toxicity at supplemental doses.
Pregnancy safety data is limited. Standard prenatal vitamins contain B1 (thiamine) at appropriate doses. Don't add high-dose benfotiamine during pregnancy without your OB's input — get B1 from food and prenatal coverage instead.
People with sulfite sensitivity (rare benfotiamine reactions) and those scheduled for surgery should consult their clinician. Otherwise benfotiamine is broadly safe with no major contraindications. Always coordinate with your prescriber if you're managing diabetic neuropathy or on neuropathic-pain medications.